Search

everythinglearnresearchcommunity

for

Search:↓

Most patients treated with low-dose alpha-interferon for malignant melanoma experienced skin side effects, with hair loss being the most frequent.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Many people in Fez-Meknes use potentially toxic plants for various health and cosmetic purposes, but more research is needed to ensure their safety.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Antiandrogens help treat hormone-related conditions in both men and women.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

The document concludes that Rabson-Mendenhall syndrome requires novel treatments for insulin resistance and emphasizes the importance of dental care in affected patients.

New acne treatments show promise as alternatives to traditional therapies.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Tianeptine, an antidepressant, may prevent stress-induced hair loss in mice.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Some treatments like minoxidil, finasteride, and dutasteride are effective for hair loss, but there's no agreed best treatment.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

The document concludes that syphilis has varied symptoms that are often missed, making clinical awareness crucial for diagnosis.

Some men taking finasteride for hair loss may experience sexual problems like erectile dysfunction and decreased sex drive, which can persist even after stopping the medication.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.